BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/22/2021 10:39:22 AM | Browse: 493 | Download: 992
 |
Received |
|
2021-03-12 14:18 |
|
Peer-Review Started |
|
2021-03-12 14:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-06 03:31 |
|
Revised |
|
2021-04-19 19:59 |
|
Second Decision |
|
2021-04-28 07:51 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-28 08:20 |
|
Articles in Press |
|
2021-04-28 08:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-10 09:52 |
|
Publish the Manuscript Online |
|
2021-05-22 10:39 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Cellular based treatment modalities for unresectable hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Konstantinos Damiris, Hamza Abbad and Nikolaos Pyrsopoulos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nikolaos Pyrsopoulos, FAASLD, AGAF, FACG, MD, PhD, Professor, Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, 185 South Orange Ave, Newark, NJ 07103, United States. pyrsopni@njms.rutgers.edu |
| Key Words |
Hepatocellular carcinoma; Immunotherapy; Immune cells; Adoptive T cell therapy; Chimeric antigen receptor-T cell; Clinical trials |
| Core Tip |
Over the recent years investigation for safe and effective treatments for unresectable hepatocellular carcinoma (HCC) has shifted focus from various chemotherapeutic agents to immune based therapy. Although far from being finalized, immune cell-based therapy has shown efficacy in a variety of clinical trials, indicating possible future utilization alone or in combination for the prevention and treatment of HCC. |
| Publish Date |
2021-05-22 10:39 |
| Citation |
Damiris K, Abbad H, Pyrsopoulos N. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World J Clin Oncol 2021; 12(5): 290-308 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i5/290.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i5.290 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
